LoginSite MapContact Us
Click to submit search
  Donate Now!
SMA ResearchFSMA CommunitySMA Fundraising
Newly DiagnosedUnderstanding SMASpinal Muscular Atrophy ConferenceFor ResearchersFor MediaAbout Families of SMA
new directions banner

Connect with Families of SMA:
FacebookBanner

TwitterBanner

YouTubeBanner

SMA Drugs in Development:

Latest News
April 24, 2014   Families of Spinal Muscular Atrophy is Currently Funding 24 Research Projects with Multiple Rounds of New Funding to be Announced in 2014.
Later in 2014 Requests for Proposals (RFPs) with new funding announcements will be made for over $1.5 Million.
 
April 23, 2014   Phase I Clinical Trial of Systemic SMN Gene Therapy For Spinal Muscular Atrophy To Begin at Nationwide Children’s Hospital in May.
 
April 23, 2014   New Edition of Compass Newsletter on Spinal Muscular Atrophy Clinical Care Research Grants.
 
April 16, 2014   Presenters Announced for The Family and Researcher Poster Session at The Annual Spinal Muscular Atrophy Conference.
Over thirty posters will be presented during the session.
 
April 15, 2014   Update on Families of Spinal Muscular Atrophy Funding to The California Institute of Biomedical Research
Developing new therapies for SMA is the driving force behind Families of SMA funding strategy. To achieve this goal, Families of SMA funds successful and innovative scientists like Dr. Peter Schultz.
 
April 10, 2014   Families of Spinal Muscular Atrophy Thanks our Sponsors for The 2014 Annual SMA Conference.
Families of SMA is pleased to announce that we currently have 18 sponsors registered for the upcoming 2014 Annual SMA Conference.
 
April 9, 2014   Families of Spinal Muscular Atrophy Awards New Research Funding of $50,000 to Dr. Lyndsay Murray.
Lyndsay Murray of The University of Edinburgh will explore the reasons causing motor neuron cell death in SMA.
 
April 8, 2014   Families of Spinal Muscular Atrophy Announces Panelists for The Research Question and Answer Session at The 2014 Annual SMA Conference.
Leading experts will address new advances, strategies, and challenges in SMA drug development.
 

 
 
Site Map Contact Us Privacy Policy Legal Terms & Conditions